Literature DB >> 28007993

Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.

Gerald Ponath1, Sriram Ramanan2, Mayyan Mubarak2, William Housley2, Seunghoon Lee3, F Rezan Sahinkaya4, Alexander Vortmeyer5, Cedric S Raine6, David Pitt2.   

Abstract

Astrocytes are key players in the pathology of multiple sclerosis and can assume beneficial and detrimental roles during lesion development. The triggers and timing of the different astroglial responses in acute lesions remain unclear. Astrocytes in acute multiple sclerosis lesions have been shown previously to contain myelin debris, although its significance has not been examined. We hypothesized that myelin phagocytosis by astrocytes is an early event during lesion formation and leads to astroglial immune responses. We examined multiple sclerosis lesions and other central nervous system pathologies with prominent myelin injury, namely, progressive multifocal leukoencephalopathy, metachromatic leukodystrophy and subacute infarct. In all conditions, we found that myelin debris was present in most astrocytes at sites of acute myelin breakdown, indicating that astroglial myelin phagocytosis is an early and prominent feature. Functionally, myelin debris was taken up by astrocytes through receptor-mediated endocytosis and resulted in astroglial NF-κB activation and secretion of chemokines. These in vitro results in rats were validated in human disease where myelin-positive hypertrophic astrocytes showed increased nuclear localization of NF-κB and elevated chemokine expression compared to myelin-negative, reactive astrocytes. Thus, our data suggest that myelin uptake is an early response of astrocytes in diseases with prominent myelin injury that results in recruitment of immune cells. This first line response of astrocytes to myelin injury may exert beneficial or detrimental effects on the lesion pathology, depending on the inflammatory context. Modulating this response might be of therapeutic relevance in multiple sclerosis and other demyelinating conditions.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  T-lymphocytes; astrocyte; demyelination; multiple sclerosis and neuroinflammation; neuroimmunology

Mesh:

Substances:

Year:  2016        PMID: 28007993      PMCID: PMC5841057          DOI: 10.1093/brain/aww298

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  37 in total

1.  Myelin debris clearance during Wallerian degeneration in the goldfish visual system.

Authors:  J Colavincenzo; R L Levine
Journal:  J Neurosci Res       Date:  2000-01-01       Impact factor: 4.164

2.  Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis.

Authors:  Leonie A Boven; Marjan Van Meurs; Marloes Van Zwam; Annet Wierenga-Wolf; Rogier Q Hintzen; Rolf G Boot; Johannes M Aerts; Sandra Amor; Edward E Nieuwenhuis; Jon D Laman
Journal:  Brain       Date:  2005-12-19       Impact factor: 13.501

Review 3.  LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system.

Authors:  Steven L Gonias; W Marie Campana
Journal:  Am J Pathol       Date:  2013-10-12       Impact factor: 4.307

4.  Myelination in rat brain: method of myelin isolation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

5.  Experimental allergic encephalomyelitis: an ultrastructural study of experimental demyelination in vitro.

Authors:  C S Raine; M B Bornstein
Journal:  J Neuropathol Exp Neurol       Date:  1970-04       Impact factor: 3.685

6.  Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis.

Authors:  Alban Gaultier; Xiaohua Wu; Natacha Le Moan; Shinako Takimoto; Gatambwa Mukandala; Katerina Akassoglou; W Marie Campana; Steven L Gonias
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

7.  Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease.

Authors:  Annika Mehlem; Carolina E Hagberg; Lars Muhl; Ulf Eriksson; Annelie Falkevall
Journal:  Nat Protoc       Date:  2013-05-23       Impact factor: 13.491

8.  Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.

Authors:  Thomas Skripuletz; Diane Hackstette; Katharina Bauer; Viktoria Gudi; Refik Pul; Elke Voss; Katharina Berger; Markus Kipp; Wolfgang Baumgärtner; Martin Stangel
Journal:  Brain       Date:  2012-12-24       Impact factor: 13.501

9.  Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis.

Authors:  David Pitt; Iris E Nagelmeier; Heather C Wilson; Cedric S Raine
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

10.  Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.

Authors:  Wolfgang Brück; Ramona Pförtner; Trinh Pham; Jingya Zhang; Liat Hayardeny; Victor Piryatinsky; Uwe-Karsten Hanisch; Tommy Regen; Denise van Rossum; Lars Brakelmann; Karin Hagemeier; Tanja Kuhlmann; Christine Stadelmann; Gareth R John; Nadine Kramann; Christiane Wegner
Journal:  Acta Neuropathol       Date:  2012-07-06       Impact factor: 17.088

View more
  50 in total

Review 1.  Astroglial vesicular network: evolutionary trends, physiology and pathophysiology.

Authors:  R Zorec; V Parpura; A Verkhratsky
Journal:  Acta Physiol (Oxf)       Date:  2017-08-03       Impact factor: 6.311

2.  Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

Authors:  Kofi Deh; Gerald D Ponath; Zaki Molvi; Gian-Carlo T Parel; Kelly M Gillen; Shun Zhang; Thanh D Nguyen; Pascal Spincemaille; Yinghua Ma; Ajay Gupta; Susan A Gauthier; David Pitt; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2018-03-08       Impact factor: 4.813

3.  A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Authors:  Xiao-Lu Yuan; Yi-Peng Zhao; Jie Huang; Jun-Chen Liu; Wen-Qian Mao; Jun Yin; Bi-Wen Peng; Wan-Hong Liu; Song Han; Xiao-Hua He
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

4.  Remyelination and the gut-brain axis.

Authors:  Ian D Duncan; Jyoti J Watters
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

Review 5.  The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Roberta Brambilla
Journal:  Acta Neuropathol       Date:  2019-03-07       Impact factor: 17.088

Review 6.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

Review 7.  Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity.

Authors:  Colm Cunningham; Aisling Dunne; Ana Belen Lopez-Rodriguez
Journal:  Neuroscientist       Date:  2018-11-17       Impact factor: 7.519

Review 8.  Diversity and Function of Glial Cell Types in Multiple Sclerosis.

Authors:  Lucas Schirmer; Dorothy P Schafer; Theresa Bartels; David H Rowitch; Peter A Calabresi
Journal:  Trends Immunol       Date:  2021-02-13       Impact factor: 16.687

Review 9.  Astrocyte phenotypes: Emphasis on potential markers in neuroinflammation.

Authors:  Iva Bozic; Danijela Savic; Irena Lavrnja
Journal:  Histol Histopathol       Date:  2020-11-23       Impact factor: 2.303

10.  Ethyl Pyruvate-Derived Transdifferentiation of Astrocytes to Oligodendrogenesis in Cuprizone-Induced Demyelinating Model.

Authors:  Yan He; Jun An; Jun-Jun Yin; Qiang Miao; Ruo-Xuan Sui; Qing-Xian Han; Zhi-Bin Ding; Jian-Jun Huang; Cun-Gen Ma; Bao-Guo Xiao
Journal:  Neurotherapeutics       Date:  2020-11-02       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.